Eligible patients with leukaemia will have access to $25 scripts for two new treatments following their expanded listing on ...

The team at the Colliery Inn, Hetton-le-Hole, have hosted a 'heart-warming' event for Avarni-Mae and her parents Chanelle ...

A benefit concert is being held on May 31st at the Bad Apple Saloon in Cory to raise money for 7-year-old Joel Beatty and his ...

Chanelle Midgley and Daniel Davis' daughter Avarni-Mae has T Lymphoblastic Lymphoma Leukaemia, but has been 'so much better' recently ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...

Hyderabad: A two judge panel of the Telangana High Court upheld a Family Court order refusing divorce to a woman, ruling that unsubstantiated allegations of cruelty and extra-marital affairs against ...

Improved BTK selectivity with zanubrutinib is associated with fewer off-target toxicities that commonly limit ibrutinib, ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...

BeOne Medicines’ sonrotoclax receives US FDA approval as first and only BCL2 inhibitor for R/R mantle cell lymphoma: San Carlos, California Saturday, May 16, 2026, 14:00 Hrs [IS ...

Head-to-Head Study Highlights Rocbrutinib as the World's First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resistance Mutations ...